Back |
home / stock / fbrx / fbrx message board
Subject | By | Source | When |
---|---|---|---|
Come on rally! | Bigbruin | investorshub | 09/03/2021 5:01:24 PM |
znewcar1: TOCA 33% v1,4M c1.57 f23,9M H1.69 S1.52 | znewcar1 | investorshangout | 05/18/2020 8:44:22 PM |
znewcar1: TOCA 56% v6,5M c2.88 f23,8M H3 EOD push. saw the BO2 thought $3 was doable. | znewcar1 | investorshangout | 03/06/2020 10:08:10 PM |
znewcar1: TOCA 34% v1,9M c1.915 f23,8M H1.93 S@1.3 | znewcar1 | investorshangout | 03/02/2020 9:46:04 PM |
znewcar1: TOCA 111% v50,9M c1.900f 23,8M H2.35 EOD push BO1 never looked back | znewcar1 | investorshangout | 02/21/2020 9:15:57 PM |
znewcar1: TOCA 85% v18,0M c.900 f23,8M H.98 EOD push gap up@.8 was a dip dip slide to LBB@.635 only | znewcar1 | investorshangout | 02/20/2020 9:17:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Forte Biosciences Inc. Company Name:
FBRX Stock Symbol:
NASDAQ Market:
Forte Biosciences Inc. Website:
Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced first quarter 2024 results and provided a business update. First Quarter 2024 Business Highlights ȁ...
Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its 2023 results and provided a business update. 2023 Business Highlights “Forte achieved a major...